• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清道夫受体在纳米治疗药物安全研发中的意义。

Implications of scavenger receptors in the safe development of nanotherapeutics.

作者信息

Shannahan Jonathan H, Bai Wei, Brown Jared M

机构信息

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.

出版信息

Receptors Clin Investig. 2015;2(3):e811. doi: 10.14800/rci.811.

DOI:10.14800/rci.811
PMID:26005702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4437212/
Abstract

Nanomaterials (NMs) are being utilized in a variety of biomedical applications including drug delivery, diagnostics, and therapeutic targeting. These applications are made possible due to the unique physicochemical properties that are exhibited at the nanoscale. To ensure safe development of NMs for clinical use, it is necessary to understand their interactions with cells and specifically cell surface receptors, which will facilitate either their toxicity and/or clinical function. Recently our research and others have investigated the role of scavenger receptors in mediating NM-cell interactions and responses. Scavenger receptors are expressed by a variety of cell types that are first to encounter NMs during clinical use such as macrophages and endothelial cells. Scavenger receptors are recognized to facilitate uptake of a wide variety of ligands ranging from foreign substances to endogenous lipids/proteins. While interaction of NMs with scavenger receptors may allow therapeutic targeting in some instances, it also presents a challenge for the stealth delivery of NMs and avoidance of the scavenging capability of this class of receptors. Due to their role in facilitating immune responses, scavenger receptor-mediated inflammation is also of concern following NM delivery. The research highlighted in this brief review intends to summarize our current understanding regarding the consequences of NM-scavenger receptor interactions.

摘要

纳米材料(NMs)正被应用于各种生物医学领域,包括药物递送、诊断和治疗靶向。由于纳米尺度下展现出的独特物理化学性质,这些应用得以实现。为确保纳米材料临床应用的安全开发,有必要了解它们与细胞尤其是细胞表面受体的相互作用,这将有助于了解其毒性和/或临床功能。最近,我们和其他研究团队研究了清道夫受体在介导纳米材料与细胞相互作用及反应中的作用。清道夫受体由多种细胞类型表达,这些细胞类型在临床应用中最先接触纳米材料,如巨噬细胞和内皮细胞。清道夫受体被认为有助于摄取从外来物质到内源性脂质/蛋白质等多种配体。虽然在某些情况下,纳米材料与清道夫受体的相互作用可能有助于治疗靶向,但这也给纳米材料的隐形递送以及规避这类受体的清除能力带来了挑战。由于它们在促进免疫反应中的作用,纳米材料递送后,清道夫受体介导的炎症也备受关注。本简要综述中强调的研究旨在总结我们目前对纳米材料与清道夫受体相互作用后果的理解。

相似文献

1
Implications of scavenger receptors in the safe development of nanotherapeutics.清道夫受体在纳米治疗药物安全研发中的意义。
Receptors Clin Investig. 2015;2(3):e811. doi: 10.14800/rci.811.
2
Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation.CD36和A类清道夫受体在人冠状动脉中的定位——两种受体在斑块形成中的作用可能存在差异。
Atherosclerosis. 2001 Jun;156(2):297-305. doi: 10.1016/s0021-9150(00)00662-6.
3
Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A.缺乏清道夫受体MARCO和SR-A的小鼠脾脏边缘区微结构缺陷及对非胸腺依赖性2型抗原的反应受损。
J Immunol. 2005 Dec 15;175(12):8173-80. doi: 10.4049/jimmunol.175.12.8173.
4
Scavenger receptors for oxidized and glycated proteins.氧化和糖化蛋白的清道夫受体
Amino Acids. 2003 Dec;25(3-4):283-92. doi: 10.1007/s00726-003-0029-5. Epub 2003 Aug 21.
5
[The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. Part 1. The structure of receptors, their ligand binding repertoires and ability to initiate intracellular signaling].[A类清道夫受体SR-A和MARCO在免疫系统中的作用。第1部分。受体的结构、其配体结合谱以及启动细胞内信号传导的能力]
Postepy Hig Med Dosw (Online). 2012 Feb 29;66:104-19. doi: 10.5604/17322693.984079.
6
Challenges facing nanotoxicology and nanomedicine due to cellular diversity.细胞多样性给纳米毒理学和纳米医学带来的挑战。
Clin Chim Acta. 2018 Dec;487:186-196. doi: 10.1016/j.cca.2018.10.004. Epub 2018 Oct 3.
7
Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis.氧化型低密度脂蛋白及清道夫受体SR-AI、CD36和LOX-1在主动脉瓣狭窄中的潜在病理作用。
Atherosclerosis. 2014 Aug;235(2):398-407. doi: 10.1016/j.atherosclerosis.2014.05.933. Epub 2014 May 29.
8
CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells.CD36不参与肝内皮细胞对乙醇醛和甲基乙二醛修饰蛋白的清道夫受体介导的内吞摄取。
J Biochem. 2005 May;137(5):607-16. doi: 10.1093/jb/mvi071.
9
Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.研究纳米材料危害与物理化学性质之间的关系:为治疗和诊断应用中纳米材料的开发提供信息。
J Control Release. 2012 Dec 28;164(3):307-13. doi: 10.1016/j.jconrel.2012.08.018. Epub 2012 Aug 23.
10
C-reactive protein uptake by macrophage cell line via class-A scavenger receptor.通过 A 类清道夫受体介导的巨噬细胞系摄取 C 反应蛋白。
Clin Chem. 2010 Mar;56(3):478-81. doi: 10.1373/clinchem.2009.140202. Epub 2010 Jan 14.

引用本文的文献

1
Multivalent Co-assembly of LL37-CpG nanoparticles: Enhanced immune response through activating multiple cell internalization pathways.LL37-CpG纳米颗粒的多价共组装:通过激活多种细胞内化途径增强免疫反应。
Mater Today Bio. 2025 Jun 21;33:102011. doi: 10.1016/j.mtbio.2025.102011. eCollection 2025 Aug.
2
The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson's disease.NFKB1 对 CD200R1 表达的调控及其在帕金森病中的潜在作用。
J Neuroinflammation. 2024 Sep 18;21(1):229. doi: 10.1186/s12974-024-03231-3.
3
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.脑靶向药物递送 - 通过脑靶向配体将纳米囊泡递送到特定的脑细胞。
J Nanobiotechnology. 2024 May 17;22(1):260. doi: 10.1186/s12951-024-02511-7.
4
Liposome-Mediated Anti-Viral Drug Delivery Across Blood-Brain Barrier: Can Lipid Droplet Target Be Game Changers?脂质体介导的抗逆病毒药物经血脑屏障传递:脂滴靶点可否成为改变游戏规则者?
Cell Mol Neurobiol. 2023 Dec 20;44(1):9. doi: 10.1007/s10571-023-01443-4.
5
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System.纳米颗粒的生物学特性:蛋白质冠层的形成及其与免疫系统的相互作用。
Pharmaceutics. 2022 Nov 26;14(12):2605. doi: 10.3390/pharmaceutics14122605.
6
Influence of Impurities from Manufacturing Process on the Toxicity Profile of Boron Nitride Nanotubes.制造过程杂质对氮化硼纳米管毒性特征的影响。
Small. 2022 Dec;18(52):e2203259. doi: 10.1002/smll.202203259. Epub 2022 Nov 14.
7
Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture.从表面结构设计角度定义岩藻聚糖硫酸酯包覆 PIBCA 纳米粒子的内吞途径。
Pharm Res. 2022 Jun;39(6):1135-1150. doi: 10.1007/s11095-022-03202-4. Epub 2022 Mar 1.
8
Mechanisms Involved in Microglial-Interceded Alzheimer's Disease and Nanocarrier-Based Treatment Approaches.小胶质细胞介导的阿尔茨海默病相关机制及基于纳米载体的治疗方法
J Pers Med. 2021 Oct 29;11(11):1116. doi: 10.3390/jpm11111116.
9
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).纳米技术在防治病毒相关呼吸道传染病(VARID)的药物和疫苗传递方面的新进展。
Int J Mol Sci. 2021 Jun 28;22(13):6937. doi: 10.3390/ijms22136937.
10
Insights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment.用于胶质母细胞瘤治疗的多功能纳米颗粒药物递送系统的见解
Molecules. 2021 Apr 14;26(8):2262. doi: 10.3390/molecules26082262.

本文引用的文献

1
Multiscale Imaging of Nanoparticle Drug Delivery.纳米颗粒药物递送的多尺度成像
Curr Drug Targets. 2015;16(6):560-70. doi: 10.2174/1389450116666150202163022.
2
Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.银纳米颗粒的物理化学性质对肥大细胞活化和脱颗粒的影响。
Toxicol In Vitro. 2015 Feb;29(1):195-203. doi: 10.1016/j.tiv.2014.10.008.
3
Nanomedicines for antimicrobial interventions.用于抗菌干预的纳米药物。
J Hosp Infect. 2014 Dec;88(4):183-90. doi: 10.1016/j.jhin.2014.09.009. Epub 2014 Oct 2.
4
Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors.银纳米颗粒上蛋白质冠的形成通过清道夫受体介导细胞毒性。
Toxicol Sci. 2015 Jan;143(1):136-46. doi: 10.1093/toxsci/kfu217. Epub 2014 Oct 17.
5
Scavenger receptor-A (CD204): a two-edged sword in health and disease.清道夫受体-A(CD204):健康与疾病中的双刃剑。
Crit Rev Immunol. 2014;34(3):241-61. doi: 10.1615/critrevimmunol.2014010267.
6
The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution.尺寸对巨噬细胞细胞模型和肺上皮细胞系中 Ag 纳米球毒性的影响取决于颗粒的溶解。
Int J Mol Sci. 2014 Apr 22;15(4):6815-30. doi: 10.3390/ijms15046815.
7
Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation.氧化锌纳米颗粒诱导单核细胞迁移和黏附在内皮细胞上,并加速泡沫细胞的形成。
Toxicol Appl Pharmacol. 2014 Jul 1;278(1):16-25. doi: 10.1016/j.taap.2014.04.010. Epub 2014 Apr 16.
8
Engineered nanomaterial exposure and the risk of allergic disease.工程纳米材料暴露与过敏性疾病风险。
Curr Opin Allergy Clin Immunol. 2014 Apr;14(2):95-9. doi: 10.1097/ACI.0000000000000031.
9
Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.清道夫受体 B1 是人类鼻咽癌的潜在生物标志物,其生长受 HDL 模拟纳米颗粒的抑制。
Theranostics. 2013 Jun 25;3(7):477-86. doi: 10.7150/thno.6617. Print 2013.
10
Dysregulation of macrophage activation profiles by engineered nanoparticles.工程纳米颗粒对巨噬细胞激活状态的调控异常。
ACS Nano. 2013 Aug 27;7(8):6997-7010. doi: 10.1021/nn402145t. Epub 2013 Jul 9.